Spotlight -

Introducing PsychiatryLive!|

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Daniel J. Müller, MD, PhD

Articles by Daniel J. Müller, MD, PhD

Using Pharmacogenetics in Making Treatment Decisions for Schizophrenia

ByKazunari Yoshida, MD, PhD,Daniel J. Müller, MD, PhD

March 29th 2019

Latest Updated Articles

Using Pharmacogenetics in Making Treatment Decisions for Schizophrenia
March 29th 2019

Trending on Psychiatric Times

Major Depressive Disorder With Mixed Features: Diagnosis and Treatment

FDA Shelves Fast-Track Drug Review Initiative

New National Guidance for Managing Medetomidine Intoxication and Withdrawal

Ahead of the FDA Action Date: A Timeline of Igalmi for Agitation in Bipolar Disorder and Schizophrenia

Oveporexton Now Available: First and Only Orexin Agonist for Narcolepsy Type 1